Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Aquis AQSE - Delayed Quote GBp

DXS International PLC (DXSP.AQ)

Compare
1.8750
-0.6750
(-26.47%)
At close: April 4 at 12:43:11 PM GMT+1
Loading Chart for DXSP.AQ
  • Previous Close 2.5500
  • Open 1.8750
  • Bid 2.0000 x --
  • Ask 3.5000 x --
  • Day's Range 1.8750 - 1.8750
  • 52 Week Range 0.0088 - 1.8750
  • Volume 112,500
  • Avg. Volume 0
  • Market Cap (intraday) 2.327M
  • Beta (5Y Monthly) 0.59
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0700
  • Earnings Date Jan 21, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

DXS International PLC, a healthcare IT company, develops and distributes clinical decision support solutions to general practitioners, nurses, and retail pharmacies in the United Kingdom and South Africa. The company offers Point-of-Care, a decision support solution; ExpertCare, a medicines optimization solution; and Smarts Referrals Solution, which speeds up referrals from primary to secondary care. It also distributes, integrates, and maintains computer software products. DXS International PLC was incorporated in 2007 and is based in Elstead, the United Kingdom.

www.dxs-systems.co.uk

71

Full Time Employees

April 30

Fiscal Year Ends

Recent News: DXSP.AQ

View More

Performance Overview: DXSP.AQ

Trailing total returns as of 4/5/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

DXSP.AQ
10,614.29%
MSCI WORLD (^990100-USD-STRD)
10.29%

1-Year Return

DXSP.AQ
13,788.89%
MSCI WORLD (^990100-USD-STRD)
2.24%

3-Year Return

DXSP.AQ
1,229.79%
MSCI WORLD (^990100-USD-STRD)
9.08%

5-Year Return

DXSP.AQ
1,873.68%
MSCI WORLD (^990100-USD-STRD)
0.00%

Compare To: DXSP.AQ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DXSP.AQ

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    1.12M

  • Enterprise Value

    1.72M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.34

  • Price/Book (mrq)

    2.50

  • Enterprise Value/Revenue

    0.52

  • Enterprise Value/EBITDA

    3.30

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -137.99%

  • Return on Assets (ttm)

    -4.44%

  • Return on Equity (ttm)

    -167.52%

  • Revenue (ttm)

    3.35M

  • Net Income Avi to Common (ttm)

    -4.62M

  • Diluted EPS (ttm)

    -0.0700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    96.43k

  • Total Debt/Equity (mrq)

    135.51%

  • Levered Free Cash Flow (ttm)

    4.12M

Research Analysis: DXSP.AQ

View More

Company Insights: DXSP.AQ

Research Reports: DXSP.AQ

View More